HudBay Minerals Inc (HBM)
Toronto Stock Exchange · Canada · prices in CAD · close of 27 Oct 2026
Key indicators
| Last close | CAD 32.83 |
|---|---|
| 52-week range | 20.26 – 44.48 |
| Return, 1 month / 3 months | −12.8% / +4.0% |
| Return, 1 year / 3 years | +51.8% / +444.3% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 61.1% |
| Worst drawdown (1 year) | -35.9% |
| Average daily value traded | 76.25M CAD |
| Dividend yield | 0.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
HudBay Minerals is a Canadian mining company that explores for, develops and operates mineral properties. It produces copper and zinc concentrates, with gold and silver as by-products, from mines in Manitoba and Peru. Its customers are smelters and metal traders that process concentrate into refined metals. The company is based in Toronto, Canada, and its operations span North and South America, where it also carries out exploration and development work around its existing mining properties.
On this site HudBay Minerals Inc appears as a stock on the Toronto Stock Exchange (Canada), code HBM, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
HudBay Minerals Inc (HBM) trades on the Toronto Stock Exchange in Canada. It last closed at CAD 32.83 on 27 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 412 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 51.8% and over the last three months it rose 4.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 51 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -4.8% | ||
| From 52-week high | -25.5% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 4.0% | ||
| 6-month return | -1.4% | ||
| 12-month return, skipping the last month | 74.1% | ||
| Stability (higher is calmer) | 35 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 61.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -35.9% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 76.25M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 16 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.1% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.3% |
|---|---|
| 1 month | −12.8% |
| 3 months | +4.0% |
| 6 months | −1.4% |
| 1 year | +51.8% |
| 3 years | +444.3% |
| 5 years | +285.7% |
Signals
| 50-day / 200-day average | 37.16 / 34.50 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.67 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Sep 2026 | CAD 0.0100 |
| 9 Jun 2026 | CAD 0.0100 |
| 10 Mar 2026 | CAD 0.0100 |
| 2 Sep 2025 | CAD 0.0100 |
| 4 Mar 2025 | CAD 0.0100 |
| 3 Sep 2024 | CAD 0.0100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.